首页> 外文期刊>International Scholarly Research Notices >Construction of a Drug Safety Assurance Information System Based on Clinical Genotyping
【24h】

Construction of a Drug Safety Assurance Information System Based on Clinical Genotyping

机译:基于临床基因分型的药品安全保证信息系统的构建

获取原文
           

摘要

To capitalize on the vast potential of patient genetic information to aid in assuring drug safety, a substantial effort is needed in both the training of healthcare professionals and the operational enablement of clinical environments. Our research aims to satisfy these needs through the development of a drug safety assurance information system (GeneScription) based on clinical genotyping that utilizes patient-specific genetic information to predict and prevent adverse drug responses. In this paper, we present the motivations for this work, the algorithms at the heart of GeneScription, and a discussion of our system and its uses. We also describe our efforts to validate GeneScription through its evaluation by practicing pharmacists and pharmacy professors and its repeated use in training pharmacists. The positive assessment of the GeneScription software tool by these domain experts provides strong validation of the importance, accuracy, and effectiveness of GeneScription.
机译:为了利用患者遗传信息的巨大潜力来帮助确保药物安全,在医疗保健专业人员的培训和临床环境的操作支持方面都需要付出巨大的努力。我们的研究旨在通过开发基于临床基因分型的药物安全保证信息系统(GeneScription)来满足这些需求,该系统利用患者特定的遗传信息来预测和预防药物不良反应。在本文中,我们介绍了这项工作的动机,GeneScription的核心算法以及对我们的系统及其使用的讨论。我们还将描述我们通过实践药剂师和药学教授进行的评估以及在培训药剂师中的重复使用来验证GeneScription的努力。这些领域的专家对GeneScription软件工具的积极评估提供了对GeneScription重要性,准确性和有效性的有力验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号